278 related articles for article (PubMed ID: 20876623)
1. Persistent Candida albicans colonization and molecular mechanisms of azole resistance in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients.
Siikala E; Rautemaa R; Richardson M; Saxen H; Bowyer P; Sanglard D
J Antimicrob Chemother; 2010 Dec; 65(12):2505-13. PubMed ID: 20876623
[TBL] [Abstract][Full Text] [Related]
2. Decreased susceptibility of Candida albicans to azole antifungals: a complication of long-term treatment in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients.
Rautemaa R; Richardson M; Pfaller M; Koukila-Kähkölä P; Perheentupa J; Saxén H
J Antimicrob Chemother; 2007 Oct; 60(4):889-92. PubMed ID: 17704513
[TBL] [Abstract][Full Text] [Related]
3. Activity of amphotericin B, anidulafungin, caspofungin, micafungin, posaconazole, and voriconazole against Candida albicans with decreased susceptibility to fluconazole from APECED patients on long-term azole treatment of chronic mucocutaneous candidiasis.
Rautemaa R; Richardson M; Pfaller MA; Perheentupa J; Saxén H
Diagn Microbiol Infect Dis; 2008 Oct; 62(2):182-5. PubMed ID: 18597968
[TBL] [Abstract][Full Text] [Related]
4. ADH1 expression inversely correlates with CDR1 and CDR2 in Candida albicans from chronic oral candidosis in APECED (APS-I) patients.
Siikala E; Bowyer P; Richardson M; Saxen H; Sanglard D; Rautemaa R
FEMS Yeast Res; 2011 Sep; 11(6):494-8. PubMed ID: 21585651
[TBL] [Abstract][Full Text] [Related]
5. Microbiological screening of Irish patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy reveals persistence of Candida albicans strains, gradual reduction in susceptibility to azoles, and incidences of clinical signs of oral candidiasis without culture evidence.
McManus BA; McGovern E; Moran GP; Healy CM; Nunn J; Fleming P; Costigan C; Sullivan DJ; Coleman DC
J Clin Microbiol; 2011 May; 49(5):1879-89. PubMed ID: 21367996
[TBL] [Abstract][Full Text] [Related]
6. Reduction of fluconazole susceptibility of Candida albicans in APECED patients due to long-term use of ketoconazole and miconazole.
Rautemaa R; Richardson M; Pfaller M; Perheentupa J; Saxen H
Scand J Infect Dis; 2008; 40(11-12):904-7. PubMed ID: 18651265
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of fluconazole resistance in a case of Candida albicans ocular infection.
Pancholi P; Park S; Perlin D; Kubin C; Della-Latta P
J Clin Microbiol; 2004 Dec; 42(12):5938-9. PubMed ID: 15583347
[TBL] [Abstract][Full Text] [Related]
8. RTA2, a novel gene involved in azole resistance in Candida albicans.
Jia XM; Ma ZP; Jia Y; Gao PH; Zhang JD; Wang Y; Xu YG; Wang L; Cao YY; Cao YB; Zhang LX; Jiang YY
Biochem Biophys Res Commun; 2008 Sep; 373(4):631-6. PubMed ID: 18601908
[TBL] [Abstract][Full Text] [Related]
9. New evidence that Candida albicans possesses additional ATP-binding cassette MDR-like genes: implications for antifungal azole resistance.
Walsh TJ; Kasai M; Francesconi A; Landsman D; Chanock SJ
J Med Vet Mycol; 1997; 35(2):133-7. PubMed ID: 9147273
[TBL] [Abstract][Full Text] [Related]
10. Reduced susceptibility of Candida albicans clinical isolates to azoles and detection of mutations in the ERG11 gene.
Zhang L; Yang HF; Liu YY; Xu XH; Ye Y; Li JB
Diagn Microbiol Infect Dis; 2013 Dec; 77(4):327-9. PubMed ID: 24070847
[TBL] [Abstract][Full Text] [Related]
11. Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient.
White TC; Pfaller MA; Rinaldi MG; Smith J; Redding SW
Oral Dis; 1997 May; 3 Suppl 1():S102-9. PubMed ID: 9456667
[TBL] [Abstract][Full Text] [Related]
12. Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes.
Müller FM; Staudigel A; Salvenmoser S; Tredup A; Miltenberger R; Herrmann JV
Antimicrob Agents Chemother; 2007 Aug; 51(8):3014-6. PubMed ID: 17548494
[TBL] [Abstract][Full Text] [Related]
13. Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes.
Ricardo E; Costa-de-Oliveira S; Dias AS; Guerra J; Rodrigues AG; Pina-Vaz C
FEMS Yeast Res; 2009 Jun; 9(4):618-25. PubMed ID: 19416368
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of resistance to fluconazole in Candida albicans clinical isolates from Iranian HIV-infected patients with oropharyngeal candidiasis.
Salari S; Khosravi AR; Mousavi SA; Nikbakht-Brojeni GH
J Mycol Med; 2016 Mar; 26(1):35-41. PubMed ID: 26627124
[TBL] [Abstract][Full Text] [Related]
15. Oral candidosis: characterization of a sample of recurrent infections and study of resistance determinants.
Gallè F; Sanguinetti M; Colella G; Di Onofrio V; Torelli R; Rossano F; Liguori G
New Microbiol; 2011 Oct; 34(4):379-89. PubMed ID: 22143811
[TBL] [Abstract][Full Text] [Related]
16. Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis.
Johnson EM; Warnock DW; Luker J; Porter SR; Scully C
J Antimicrob Chemother; 1995 Jan; 35(1):103-14. PubMed ID: 7768758
[TBL] [Abstract][Full Text] [Related]
17. The synergy of honokiol and fluconazole against clinical isolates of azole-resistant Candida albicans.
Jin J; Guo N; Zhang J; Ding Y; Tang X; Liang J; Li L; Deng X; Yu L
Lett Appl Microbiol; 2010 Sep; 51(3):351-7. PubMed ID: 20681969
[TBL] [Abstract][Full Text] [Related]
18. A D-octapeptide drug efflux pump inhibitor acts synergistically with azoles in a murine oral candidiasis infection model.
Hayama K; Ishibashi H; Ishijima SA; Niimi K; Tansho S; Ono Y; Monk BC; Holmes AR; Harding DR; Cannon RD; Abe S
FEMS Microbiol Lett; 2012 Mar; 328(2):130-7. PubMed ID: 22211961
[TBL] [Abstract][Full Text] [Related]
19. Candida albicans isolates from APECED patients show decreased susceptibility to miconazole.
Siikala E; Richardson M; Pfaller MA; Diekema DJ; Messer SA; Perheentupa J; Saxén H; Rautemaa R
Int J Antimicrob Agents; 2009 Dec; 34(6):607-9. PubMed ID: 19748230
[No Abstract] [Full Text] [Related]
20. Drug resistance genes and trailing growth in Candida albicans isolates.
Lee MK; Williams LE; Warnock DW; Arthington-Skaggs BA
J Antimicrob Chemother; 2004 Feb; 53(2):217-24. PubMed ID: 14688046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
